These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8144437)

  • 1. Early susceptibility test results with the Bacteroides fragilis group.
    Aldridge KE
    J Antimicrob Chemother; 1993 Dec; 32(6):910-2. PubMed ID: 8144437
    [No Abstract]   [Full Text] [Related]  

  • 2. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.
    Dubreuil L; Breuil J; Dublanchet A; Sedallian A
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1094-9. PubMed ID: 1295764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
    Betriu C; Culebras E; Gómez M; López F; Rodríguez-Avial I; Picazo JJ
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2686-90. PubMed ID: 18474575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.
    Tanaka-Bandoh K; Kato N; Watanabe K; Ueno K
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S352-5. PubMed ID: 7548596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new potent beta-lactamase inhibitor, BRL 42715, with inherent activity against Bacteroides fragilis group strains.
    Aldridge KE
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S335-8. PubMed ID: 8324143
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)].
    Borobio MV; Domínguez MC; Pallares JA; Perea EJ
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.
    Cornick NA; Cuchural GJ; Snydman DR; Jacobus NV; Iannini P; Hill G; Cleary T; O'Keefe JP; Pierson C; Finegold SM
    J Antimicrob Chemother; 1990 Jun; 25(6):1011-9. PubMed ID: 2370237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility testing of anaerobic bacteria.
    Citron D
    Am J Med Technol; 1983 Nov; 49(11):769-72. PubMed ID: 6316785
    [No Abstract]   [Full Text] [Related]  

  • 9. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
    Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance in Bacteroides.
    Wexler HM; Finegold SM
    J Antimicrob Chemother; 1987 Feb; 19(2):143-6. PubMed ID: 3553132
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents.
    Niederau W; Höffler U; Pulverer G
    Arzneimittelforschung; 1980; 30(12):2093-8. PubMed ID: 7194067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis.
    Privitera G; Dublanchet A; Sebald M
    J Infect Dis; 1979 Jan; 139(1):97-101. PubMed ID: 108340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of phosphomycin as a differential character for Gram negative anaerobic bacilli.
    Rodriguez JA; Prieto JP; Sanchez JE; Gonzalez MC; Luengo FM
    J Appl Bacteriol; 1976 Oct; 41(2):251-4. PubMed ID: 11203
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sensitivity of Bacteroides of the fragilis group to various antibiotics].
    de la Torre Misiego F; Betriú Cabecerán C; López Bartolomé O; Rodriguez Avial C; López Doriga
    Rev Clin Esp; 1981 Dec; 163(6):387-90. PubMed ID: 7342200
    [No Abstract]   [Full Text] [Related]  

  • 15. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria].
    Mittermayer H; Rotter M; Riezinger F; Thiel W; Stanek G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance profile of Bacteroides fragilis group of clinical isolates, eastern India.
    Mohanty S; Rath S
    Indian J Med Microbiol; 2021 Jul; 39(3):397-398. PubMed ID: 34167846
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro effects of cefotetan on anaerobic bacteria of the genus Bacteroides fragilis group, in comparison with 8 antibiotics].
    Trevisan R; Proietti A; Pitzus E
    G Ital Chemioter; 1985; 32(2):367-70. PubMed ID: 3869115
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug resistance of bacteria--the current status and future prospect. 6. Bacteroides].
    Okada J
    Nihon Rinsho; 1984 Mar; 42(3):690-5. PubMed ID: 6471458
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.